G-CSF and Assisted Reproductive Techniques outcomes in repeated implantation failures

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013063011653N2

Enrollment

100

Registered

2013-07-16

Start date

2013-07-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. In vitro fertilization

Interventions

Intervention 1: In Intervention group 1cc(300)microgram Granulocyte-colony stimulating factor will be injected in to uterine cavity through vagina. Intervention 2: In Control group 1cc normal salin wi

Treatment - Drugs

In Intervention group 1cc(300)microgram Granulocyte-colony stimulating factor will be injected in to uterine cavity through vagina.

In Control group 1cc normal salin will be injected in to uterine cavity through vagina.

Eligibility

Sex/Gender

Female

Age

20 Years to 38 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ART failure>3; Age:20-38; Normal karyotype and uterus anatomy; Do not have infection,endocrine and immune and coagulation disorders ,thrombophilia; Normal TSH,LH,FBS; FSH<10 TPO<500; Negative lupus anti coagulant; Negative Toxoplasma,CMV,Rhubella; Normal Factor 5leiden,factor2 prothrombin,protein C, Pr S Exclusion criteria:Azoospermia with negative testis biopsy; Egg donation; Suffering from cancer

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy. Timepoint: After intervention. Method of measurement: Gestational Sac in sonography.	—

Secondary

Measure	Time frame
Chemical pregnancy. Timepoint: After intervention. Method of measurement: HCG.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sara Mokhtar

Avicenna Infertility treatment center

smkhtr@yahoo.com+98 21 2261 7930

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026